These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 4829456

  • 21. [The current status of endocrine therapy in the palliative treatment of the metastasizing breast carcinoma in women].
    Nowakowski H.
    Chirurg; 1968 Jun; 39(6):258-63. PubMed ID: 5697277
    [No Abstract] [Full Text] [Related]

  • 22. [Radiotherapy of breast carcinoma. 2005 version].
    Organgruppe "Mammakarzinom" der DEGRO.
    Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
    [No Abstract] [Full Text] [Related]

  • 23. [Results of hormonal treatment of breast cancer with special reference to preventive therapy].
    Schmidt H, Bauer R.
    Strahlentherapie; 1968 Sep; 136(3):259-62. PubMed ID: 5685748
    [No Abstract] [Full Text] [Related]

  • 24. Surgery for T4 breast carcinoma: implications for local control.
    Yeh KA, Jillella AP, Wei JP.
    Am Surg; 2000 Mar; 66(3):250-4; discussion 255. PubMed ID: 10759194
    [Abstract] [Full Text] [Related]

  • 25. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
    Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, Menard C, Lippman ME, Lichter AS, Altemus RM.
    Cancer; 2003 Aug 15; 98(4):697-702. PubMed ID: 12910512
    [Abstract] [Full Text] [Related]

  • 26. Venous thrombosis during multimodal treatment of primary breast carcinoma.
    Weiss RB, Tormey DC, Holland JF, Weinberg VE.
    Cancer Treat Rep; 1981 Aug 15; 65(7-8):677-9. PubMed ID: 7248984
    [Abstract] [Full Text] [Related]

  • 27. [Endocrine therapy of female breast carcinoma dependent upon the number of Barr bodies].
    Klug W.
    Chirurg; 1969 Jan 15; 40(1):33-6. PubMed ID: 5350842
    [No Abstract] [Full Text] [Related]

  • 28. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1514-21. PubMed ID: 16005576
    [Abstract] [Full Text] [Related]

  • 29. Axillary lymph node metastases as the sole clinical site of occult breast carcinoma.
    Dragoumis DM, Tsiftsoglou AP, Sikou AD, Assimaki AS.
    J Coll Physicians Surg Pak; 2008 Aug 01; 18(8):517-9. PubMed ID: 18798593
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. One more change of paradigm in breast cancer treatment. Postmastectomy radiotherapy for patients with one to three lymph node metastases?
    Sautter-Bihl ML, Sauer R.
    Strahlenther Onkol; 2007 Jul 01; 183(7):357-9. PubMed ID: 17609867
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Current problems in the therapy of diffuse breast carcinoma].
    Di Pietro S.
    Minerva Radiol; 1968 Oct 01; 13(10):569-73. PubMed ID: 5734810
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.